A nurse is collecting data from a client who has been taking esomeprazole for several months. Which of the following client statements should the nurse identify as indicating effectiveness of the medication?

The nurse should measure the gastric residual before administering a feeding to identify delayed gastric emptying. Gastric residual refers to the volume of formula or contents remaining in the stomach from the previous feeding. Measuring gastric residual helps assess how well the client's stomach is emptying and can indicate if there is delayed gastric emptying.

By measuring gastric residual, the nurse can:

● Determine if the stomach has adequately emptied from the previous feeding. ● Assess the client's tolerance to enteral feedings.

● Detect signs of delayed gastric emptying, which can be indicative of gastrointestinal motility issues or other complications.

● Adjust the feeding rate or make other modifications to the enteral feeding plan based on the amount of residual volume.

Confirming the placement of the NG tube is typically done using other methods, such as an X-ray, pH testing, or auscultation of air insufflation. Gastric residual measurement primarily serves the purpose of assessing gastric emptying, rather than confirming tube placement.

While electrolyte imbalances can be monitored in the overall care of a client receiving enteral feedings, measuring gastric residual specifically focuses on assessing gastric emptying and feeding tolerance, rather than determining the client's electrolyte balance.

Removing gastric acid that might cause dyspepsia is not the primary purpose of measuring gastric residual. Gastric residual measurement aims to evaluate the volume of the previous feeding and assess gastric emptying, rather than focusing on dyspepsia specifically.

Atenolol is a beta-blocker medication commonly used to treat conditions such as hypertension (high blood pressure) and certain heart rhythm disorders. One of the intended effects of atenolol is to lower the heart rate by blocking the action of adrenaline on beta receptors in the heart. However, this can sometimes result in bradycardia, which refers to a heart rate that is slower than the normal range.

Hypokalemia, or low potassium levels, is not directly caused by atenolol but can be an indirect effect. Beta-blockers like atenolol can potentially interfere with the normal release of insulin and contribute to increased urinary excretion of potassium. Therefore, it's important to monitor potassium levels in clients taking atenolol, as low potassium levels can have adverse effects on various body systems.

Anemia and neutropenia are not typically associated with the use of atenolol. Anemia refers to a decrease in the number of red blood cells or a decrease in the amount of hemoglobin, which carries oxygen to the body tissues. Neutropenia refers to a decrease in the number of neutrophils, which are a type of white blood cell involved in fighting infection.